Literature DB >> 8061543

Primary malignant mesothelioma of the pericardium. Case report and literature review.

R Thomason1, W Schlegel, M Lucca, S Cummings, S Lee.   

Abstract

Pericardial mesothelioma is a highly lethal and fortunately rare cardiac neoplasm. We present the clinical and pathologic features of a primary sarcomatoid mesothelioma. To better understand the clinical, radiographic, and pathologic features of this entity, we reviewed 27 cases described in the English literature from 1972 through 1992, which, together with our case, provided a total of 28 cases. Findings of the review include a male-female ratio of 2:1, a wide age range (12 to 77 years; mean, 47 years), and documented asbestos exposure in 4 of 28 (14%) patients. Commonly used imaging studies do not appear to offer great sensitivity, for a mass was detected by echocardiography in only 2 of 16 (12%) patients and by computed tomography in 4 of 9 (44%). Pathologic findings revealed a diffuse growth pattern in most cases (18 of 25, or 72%), together with an equal distribution between the biphasic, epithelioid, and sarcomatoid variants. Effusion cytology revealed malignant cells in only 2 of 10 (20%) cases. With or without therapy, prognosis was uniformly poor, since 24 of 27 patients were dead of the disease at the time the reports were published.

Entities:  

Mesh:

Year:  1994        PMID: 8061543      PMCID: PMC325154     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  33 in total

1.  Primary pericardial mesothelioma: one-year event-free survival.

Authors:  C A Nambiar; H E Tareif; K U Kishore; J Ravindran; A K Banerjee
Journal:  Am Heart J       Date:  1992-09       Impact factor: 4.749

2.  Occult metastatic mesothelioma--diagnosis by fine-needle aspiration. A case report.

Authors:  F E Craig; N F Fishback; J G Schwartz; C N Powers
Journal:  Am J Clin Pathol       Date:  1992-04       Impact factor: 2.493

3.  Primary malignant mesothelioma of the pericardium.

Authors:  T Fazekas; I Ungi; L Tiszlavicz
Journal:  Am Heart J       Date:  1992-07       Impact factor: 4.749

4.  Cardiac tamponade caused by primary pericardial mesothelioma.

Authors:  J Turk; M Kenda; I Kranjec
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

5.  Primary pericardial mesothelioma presenting as tuberculous pericarditis.

Authors:  D S Rose; W T Vigneswaran; B A Bovill; J F Riordan; R N Sapsford; R D Stanbridge
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

6.  Pericardial mesothelioma: hyaluronic acid in pericardial fluid.

Authors:  K Takeda; H Ohba; H Hyodo; T Shimizu; H Iwakura; T Hayashi; H Yamamoto; S Yagi; A Take; M Harada
Journal:  Am Heart J       Date:  1985-08       Impact factor: 4.749

7.  Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.

Authors:  P T Cagle; L D Truong; V L Roggli; S D Greenberg
Journal:  Am J Clin Pathol       Date:  1989-11       Impact factor: 2.493

Review 8.  Mesotheliomas due to asbestos used in railroads in Italy.

Authors:  C Maltoni; C Pinto; A Mobiglia
Journal:  Ann N Y Acad Sci       Date:  1991-12-31       Impact factor: 5.691

9.  Primary pericardial malignant epithelioid mesothelioma causing acute myocardial infarction.

Authors:  P K Chun; W T Leeburg; J T Coggin; R Zajtchuk
Journal:  Chest       Date:  1980-04       Impact factor: 9.410

10.  Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura, and reactive submesothelial hyperplasia. An immunohistochemical comparison.

Authors:  M Al-Izzi; N P Thurlow; B Corrin
Journal:  J Pathol       Date:  1989-05       Impact factor: 7.996

View more
  23 in total

1.  Immunolocalization of caveolin-1 in rat and human mesothelium.

Authors:  Christopher J von Ruhland; Lee Campbell; Mark Gumbleton; Bharat Jasani; Geoffrey R Newman
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

2.  A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction.

Authors:  Russell Fernandes; Shravan Nosib; Dorothy Thomson; Nick Baniak
Journal:  BMJ Case Rep       Date:  2014-03-20

3.  Three-year survival after surgery for primary malignant pericardial mesothelioma: report of a case.

Authors:  Kishu Fujita; Mitsumasa Hata; Akira Sezai; Kazutomo Minami
Journal:  Surg Today       Date:  2013-02-14       Impact factor: 2.549

4.  Cytopathology of pericardial effusions : Experience from a tertiary center of cardiology.

Authors:  C Gecmen; G G Gecmen; D Ece; M Kahyaoğlu; A Kalayci; C Y Karabay; O Candan; M E Isik; F Yilmaz; O Akgun; M Celik; I A Izgi; C Kirma; S Keser
Journal:  Herz       Date:  2017-07-10       Impact factor: 1.443

5.  Malignant pericardial mesothelioma : A systematic review of current practice.

Authors:  S Cao; S Jin; J Cao; J Shen; H Zhang; Q Meng; B Pan; Y Yu
Journal:  Herz       Date:  2017-01-27       Impact factor: 1.443

6.  A Ball in the Heart: An Interesting Discovery in a Very RareCardiac Tumor.

Authors:  Ahmadreza Jodati; Babak Kazemi; Naser Safaei; Mehrnoush Toufan
Journal:  J Cardiovasc Thorac Res       Date:  2013-06-27

7.  Fatal hemopericardial tamponade due to primary pericardial mesothelioma: a case report.

Authors:  Daniel C Lingamfelter; Dominick Cavuoti; Amy C Gruszecki
Journal:  Diagn Pathol       Date:  2009-12-09       Impact factor: 2.644

8.  Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy: A case report.

Authors:  Sang Mi Chung; Seong Ji Choi; Min Jung Kim; Jung Yoon Choi; Hong Jun Kim; Suk-Young Lee; Eun Joo Kang
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

Review 9.  Pericardial mesothelioma.

Authors:  W T Vigneswaran; P R Stefanacci
Journal:  Curr Treat Options Oncol       Date:  2000-10

Review 10.  A Clinico-Pathologic Approach to the Differential Diagnosis of Pericardial Tumors.

Authors:  Alison R Krywanczyk; Carmela D Tan; E Rene Rodriguez
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.